UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

WASHINGTON,
D.C. 20549



FORM
10-Q/A



Amendment
No. 2



|[X]  | Quarterly
    Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|---- | -------------------------------------------------------------------------------------------
|     |                                                                                            
|     | For
    the quarterly period ended September 30, 2012                                      
|     |                                                                                            
|[  ] | Transition Report
    pursuant to 13 or 15(d) of the Securities Exchange Act of 1934       
|     |                                                                                            
|     | For
    the transition period from __________ to__________                                 
|     |                                                                                            
|     | Commission
    File Number: 333-168930                                                     



Nano
Mobile Healthcare, Inc.

(Exact
name of registrant as specified in its charter)



|NV                                                                 | 93-0659770                           
|------------------------------------------------------------------ | -------------------------------------
|(State
    or other jurisdiction of incorporation or organization) | (IRS
    Employer Identification No.)



|3
                            Columbus Circle, 15th Floor
        New
        York, NY 10019
|--------------------------------------------------------------------------------------------
|(Address of principal
    executive offices)                                                



|917-745-7202                                                                          
|--------------------------------------------------------------------------------------
|(Registrant’s
    telephone number)                                                   
|___________________________                                                           
|(Former
    name, former address and former fiscal year, if changed since last report)



Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days [ ] Yes [X] No



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [ ] Yes [X] No



Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company.



|[ ] Large accelerated filer | [ ] Accelerated filer        
|--------------------------- | -----------------------------
|[ ] Non-accelerated filer   | [X] Smaller reporting company



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No



Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 80,125,000
issued and outstanding as of September 30, 2012.



1







EXPLANATORY
NOTE



Nano
Mobile Healthcare, Inc. (the "Company") is filing this Amendment No.2 of Form 10-Q/A (this "Amendment") to
amend its Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (the "Original Form 10-Q"), originally
filed with the Securities and Exchange Commission on November 14, 2012, and later amended on November 26, 2012. The purpose of
this Amendment is solely to correct a typographical error which appeared on the cover page of the Original Form 10-Q, and was
reproduced in the Company’s amendment to the Original Form 10-Q, which incorrectly identified the Company as a shell company.
The Company is making this Amendment to properly check the box that says “No,” the Company is not a shell company
as defined in Rule 12b-2 of the Exchange act.



No
revisions are being made to the Company's financial statements. This Amendment speaks as of the original filing date, does not
reflect events occurring after the filing of the Original Form 10-Q or subsequent amendment, or modify or update those disclosures
that may be affected by subsequent events, and no other changes are being made to any other disclosure contained in the Original
Form 10-Q.



2







Item
6. Exhibits



|Exhibit
    Number | Description of Exhibit                                                                                                                                                                  
|------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|31.1               | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                       
|31.2               | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                       
|32.1               | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002           
|101                | The
    following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 formatted
    in Extensible Business Reporting Language (XBRL) (1)



(1) Incorporated
by reference to the form 10-Q filed with the Securities and Exchange Commission on November 14, 2012.



3





SIGNATURES



Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.



|       | Nano
    Mobile Healthcare, Inc.
|------ | --------------------------------
|       |                                 
|Date:  | October
    28, 2016            
|       | /s/
        Joseph C. Peters    
|By:    | Joseph
    C. Peters            
|Title: | Chief
    Executive Officer     



4